Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.
about
Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status.Optimizing combination therapies with existing and future CML drugsMolecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.Targeted treatment of chronic myeloid leukemia: role of imatinib.Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis.Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.Management of imatinib-resistant patients with chronic myeloid leukemia.Rapid conversion of chronic myeloid leukemia to chronic myelomonocytic leukemia in a patient on imatinib therapy.Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation.Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.Karyotypic findings in chronic myeloid leukemia cases undergoing treatment.Philadelphia chromosome-negative acute myeloid leukemia with 11q23/MLL translocation in a patient with chronic myelogenous leukemiaDasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment Options.Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia.Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.Clonal cytogenetic abnormalities after tyrosine kinase inhibitor therapy in Ph+ ALL resolution after decitabine therapy.Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
P2860
Q27853066-B1EEF851-89DD-4B3E-BACB-CA4DA6F92E52Q28475255-F5E25C43-D1A4-49C8-B673-681D99B4E37BQ33750753-0AA685A0-B591-4EA3-ADE4-14CE8BAF7447Q33915973-DC0FB817-9A68-4180-8D58-C9E37FE1B97DQ35404394-E03252C8-B0FA-4334-970B-3400A6079186Q35849776-80098DB3-D02A-4FD7-8BB7-A0E9045A9A94Q36776423-CFD1228F-A077-4CD8-AB0A-2DEA8857A292Q37389361-9EC92FF3-D6E3-4946-84E1-BF134B522ED4Q37393134-A723DFDD-BFA3-4D80-8E11-4DD0BD315027Q37651599-CAF51834-9433-44A1-B586-1298B15E7314Q40799115-BDF467FD-EB41-4F6A-8C5F-5BBED36379FCQ42149644-B3E45F0A-A099-4C33-8899-771ABEEA91D2Q42532016-A12AC08E-5C12-4D11-965E-F35C4BDD363DQ42650776-D1BA8117-9F2E-49BC-85E9-EB2C2D9892C7Q43078241-5FBBFB00-7D7A-4959-A65D-F40273875184Q43266877-821D78CD-59F7-467D-8B76-F5EF3A0ED30EQ44496127-ED1FAA7C-254F-4B9F-9356-0957968740B4Q48333828-59CAB4E4-85F3-41AF-AE20-7E484A668CF3Q54294058-5301C9CF-6592-4DA5-AE8B-41BB752066B5Q54561399-F23A0EED-F772-426F-A945-EC1F37767578Q55062685-DB121DCA-1028-4324-A8B3-DDD6C0BD04A3
P2860
Clonal cytogenetic abnormalities in Philadelphia chromosome negative cells in chronic myeloid leukemia patients treated with imatinib.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@ast
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@en
type
label
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@ast
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@en
prefLabel
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@ast
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@en
P2860
P1433
P1476
Clonal cytogenetic abnormaliti ...... atients treated with imatinib.
@en
P2093
Marc Loriaux
Michael Deininger
P2860
P304
P356
10.1080/10428190410001723278
P577
2004-11-01T00:00:00Z